ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $144 | -80.2% | 5,300 | -77.6% | 0.00% | -60.0% |
Q2 2023 | $727 | +71.9% | 23,644 | +101.5% | 0.01% | 0.0% |
Q1 2023 | $423 | -99.9% | 11,734 | -28.6% | 0.01% | -37.5% |
Q3 2022 | $660,000 | -19.7% | 16,437 | -15.9% | 0.01% | -11.1% |
Q2 2022 | $822,000 | +16.6% | 19,551 | +8.0% | 0.01% | +80.0% |
Q1 2022 | $705,000 | -24.9% | 18,096 | -30.4% | 0.01% | +25.0% |
Q3 2021 | $939,000 | +99.8% | 25,983 | +126.5% | 0.00% | +100.0% |
Q2 2021 | $470,000 | -68.7% | 11,474 | -66.6% | 0.00% | -75.0% |
Q1 2021 | $1,500,000 | +129.0% | 34,399 | +162.7% | 0.01% | +166.7% |
Q4 2020 | $655,000 | – | 13,094 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
Brown University | 621,759 | $22,470,000 | 3.05% |
Graypoint LLC | 610,584 | $22,067,000 | 2.71% |